Priya Nori, M.D.
- Associate Professor, Department of Medicine (Infectious Diseases)
- Associate Professor, Department of Orthopaedic Surgery
- Medical Director, Antibiotic Stewardship Program
Area of research
- 1. Clinical decision support tools and antibiotic prescribing 2. Medical education in ID, stewardship, and infection prevention 3. Rapid diagnostic technology and stewardship 4. COVID-19 Pandemic response, SARS-CoV-2 antiviral therapies
Phone
Location
- Montefiore Medical Center 3411 Wayne Avenue 4H Bronx, NY 10467
Research Profiles
Professional Interests
Dr. Priya Nori is an Associate Professor of Medicine (Infectious Diseases) and Orthopedic Surgery at the Albert Einstein College of Medicine. She serves as Medical Director of the Antimicrobial Stewardship Program (ASP), Outpatient Parenteral Antibiotic Therapy program (OPAT), and is Co-chair of the systems Antimicrobial Council at Montefiore Health System. She served as Program Director of the Infectious Diseases (ID) fellowship program from 2019-2022. She is an alumna of the Albert Einstein College of Medicine, where she received the American Medical Women’s Association’s Glasgow-Rubin Achievement Award and was inducted into the Alpha Omega Alpha honor society. She completed her internship at Baylor College of Medicine, residency at the New York Presbyterian Hospital, Weill Cornell. She returned to Einstein/Montefiore for fellowship in infectious diseases then stayed on as faculty. Her primary contribution to the MHS/Einstein pandemic response has been as Physician Lead of the Montefiore COVID-19 Outpatient Therapeutics Program since December 2020.
She is widely published in medical education in stewardship and infection prevention, orthopedic hardware infections, novel diagnostic technology, and COVID-19 therapeutics. She serves as chair of the Infectious Diseases Society of America’s (IDSA) Subcommittee for Antimicrobial Stewardship Curricula, chair of the SHEA Antimicrobial Stewardship Committee, and co-chaired the SHEA stewardship certificate track, 2019-2022. She is also Deputy Editor of Antimicrobial Stewardship and Healthcare Epidemiology, the SHEA open access online journal as well as Clinical Infectious Diseases Photoquiz co-editor. Under her leadership, Montefiore’s ASP was awarded the IDSA’s Stewardship Center of Excellence distinction in 2018 and 2022. She is also course director of IDSNY’s pre-meeting workshop on stewardship, infection prevention, and hospital epidemiology. She was awarded ID fellowship “teacher of the year” in 2015, the Department of Medicine “rising star” award in 2017, the "Sharon Silbiger Subspecialist Teacher of the Year" award in 2020, the March 2022 IDSA Medical Education Community of Practice's Featured Educator, and the SHEA 2023 Stewardship Scholar award.
Selected Publications
Nori P, Ostrowsky B, Dorokhova O, Gialanella P, Moy M, Muggia V, Grossberg R, Kornblum J, Lin Y, Levi MH. Use of MALDI-ToF MS to resolve complex clinical cases of patients with recurrent bacteremias. 2013. J. Clin. Microbiol. 51: 1983-1986.
Nori P, Szymczak W, Park C, Gialanella P, Munjal I, Chung P, Guo Y, Williamson J, Ostrowsky B, Levi M. Matrix-assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-ToF-MS) as a First Line Modality in the Diagnosis of Bacterial Meningitis and Septicemia – a Report of Five Cases. Clinical Microbiology Newsletter. Clinical Microbiology Newsletter, Volume 38, Issue 7, 1 April 2016: 57-60
Nori P, Madaline T, Munjal I, Bhar S, Pirofski L, Nosanchuk J, Guo Y, Chung P, Seo S, Del Castillo M, Porrovecchio A, Ostrowsky B, MD MPH. Developing Interactive Antimicrobial Stewardship and Infection Prevention Curricula for Diverse Learners: A Tailored Approach. Open Forum Infectious Diseases, Volume 4, Issue 3, 1 July 2017, ofx117,https://doi.org/10.1093/ofid/ofx117
Madaline T, Nori P (co-first authorship), Mowrey W, Zukowski E, Sarwar U, Weston G, Ehrlich A, Ostrowsky B, Corpuz M, Pirofski L. Bundle in the Bronx: Impact of a Transition-of-Care Model of Outpatient Parenteral Antibiotic Therapy (OPAT) on All Cause 30-day Hospital Readmissions. Open Forum Infectious Diseases, Volume 4, Issue 2, 1 April 2017, ofx097, https://doi.org/10.1093/ofid/ofx097
Bartash R, Guo Y, Pope J, Saraiya N, and Nori P. Periprosthetic hip joint infection with Aspergillus terreus – a clinical case and a review of the literature. Medical Mycology Case Reports, Volume 18, December 2017, Pages 24-27
Bartash R and Nori P. Beta-lactam combination therapy for treatment of Staphylococcus aureus and Enterococcus species bacteremias: A summary and appraisal of the evidence. International Journal of Infectious Diseases. August 5, 2017
Hassan S, Saraiya N, Kahn M, and Nori P. Treatment of a Complex Orthopedic Infection due to Extensively Drug Resistant Pseudomonas aeruginosa. BMJ Case Reports. 2018; doi:10.1136/bcr-2017-223202
Mittal J, Szymczak W, Robbins N., Harris C, and Nori P. An Unusual Cause of Community-acquired Pneumonia. ID Cases. 26 Dec 2017, 11:41-43
Luther VP, Shnekendorf R, Abbo LM, Advani S, Armstrong WA, Barsoumian AE, Beeler C, Bystritsky R, Cherabuddi K, Cohen S, Hamilton KW, Ince D, Justo JA, Logan, A Lynch JB, Nori P, Ohl CA, Patel PK, Pottinger PS, Schwartz B, Stack C, Zhou Y; Antimicrobial Stewardship Training for Infectious Diseases Fellows: Program Directors Identify a Curriculum Need, Clinical Infectious Diseases, ciy332, https://doi.org/10.1093/cid/ciy332
Mittal J, Szymczak W, Guo Y….and Nori, P. Two for the Price of One – An Emerging Infectious Disease in a Returning Traveller to New York City. BMJ Cases. June 2018
Cowman K, Mittal J, Weston G, Harris E. Shapiro L, Schlair Sheira, Park S, and Nori P. Understanding Drivers of Influenza-like-illness Presenteeism within Training Programs: A Survey of Trainees and Their Program Directors. American Journal of Infection Control, in press https://doi.org/10.1016/j.ajic.2019.02.004
Nori P, Bartash R, Cowman K, Dackis M, Pirofski L. Is Burnout Infectious? Understanding Drivers of Burnout and Job Satisfaction among Academic Infectious Diseases Physicians, Open Forum Infectious Diseases. ofz092 https://doi.org/10.1093/ofid/ofz092
Nori P, Cowman K, Jezek A, Nosanchuk JD, Slosar-Cheah M, Sarwar U, Bartash R, Ostrowsky B. Faces of Resistance: Using Real-world Patients and Their Advocates to Teach Medical Students about Antimicrobial Stewardship, Open Forum Infectious Diseases, ofz487, https://doi.org/10.1093/ofid/ofz487
Baron S, Ostrowsky B, Nori P, et al. Screening of Clostridiodes difficile carriers in an urban academic medical center: understanding implications of diseases. Infection Control & Hospital Epidemiology, 1-5. doi:10.1017/ice.209.309
Bartash R, Cowman K, Szymczak W, Guo Y, Ostrowsky B, Binder A, Sheridan C, Levi M, Gialanella P, and Nori P. Bundled approach to stewardship for febrile neutropenia using local treatment guidelines, MRSA epidemiology, and antibiotic-use ratios. Journal of Oncology Practice, https://doi.org/10.1200/JOP.19.00492
Wadskier-Montagne F, Cowman K, Szymczak W, Weston G, Guo Y, Bartash R, Levi M, and Nori P. Diagnostic Stewardship of Clostridioides difficile Polymerase Chain Reaction Results from Syndromic Diarrhea Panel and Implications for Patient Outcomes. Diagnostic Microbiology & Infectious Disease. Accepted February 27, 2020.
Nori P, Nadeem N, Saraiya N, Szymczak W, Boland-Reardon C, Kahn M. Beta-hemolytic group a streptococcal orthopaedic infections: Our institutional experience and review of the literature. J Orthop. 2020 Mar 24;21:150-154. doi: 10.1016/j.jor.2020.03.015. eCollection 2020 Sep-Oct. Review.
Stevens MP, Patel PK, and Nori P. Involving antimicrobial stewardship programs in COVID-19 response efforts: All hands on deck. Infect Control Hosp Epidemiol. 2020 Mar 13:1-2. doi: 10.1017/ice.2020.69. [Epub ahead of print]
Bushman D, Alroy KA, Greene SK, ...Nori, P., et al. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections – New York City, March 2020. MMWR Morb Mortal Wkly Rep 2020;69:918-922. DOI: http://dx.doi.org/10.15585/mwr.mm6928a5external_icon.
Nori, P., Cowman, K., Chen, V., Bartash R., Szymczak, W., Madaline, T.,…Guo Y. (2020). Bacterial and Fungal Co-Infections in COVID-19 Patients Hospitalized During the New York City Pandemic Surge. Infection Control & Hospital Epidemiology, 1-13. doi:10.1017/ice.2020.368
Punjabi, C., Madaline, T., Gendlina, I., Chen, V., Nori, P., & Pirofski, L. (2020). Prevalence of MRSA in Respiratory cultures and Diagnostic Performance of the MRSA Nasal PCR In Patients hospitalized with COVID-19 Pneumonia. Infection Control & Hospital Epidemiology, 1-8. doi:10.1017/ice.2020.440
Stevens MP, Patel PK, and Nori, P. Antimicrobial Stewardship Programs and Convalescent Plasma for COVID-19: A New Paradigm for Pre-Authorization? [published online ahead of print, 2020 Sep 9]. Infect Control Hosp Epidemiol. 2020;1-4. doi:10.1017/ice.2020.459
Nori, P., Szymczak W., Puius Y., et al. Emerging Co-Pathogens: New Delhi Metallo-beta-lactamase producing Enterobacterales Infections in New York City COVID-19 Patients,
International Journal of Antimicrobial Agents, 2020, 106179, ISSN 0924-8579
Patel, P., Nori, P., and Stevens, M. Antimicrobial Stewardship and Bamlanivimab: Opportunities for Outpatient Preauthorization? (2020). Infection Control & Hospital Epidemiology, 1-5. doi:10.1017/ice.2020.1343
Nori, P., Patel, P., & Stevens, M. Rational allocation of COVID-19 vaccines to healthcare personnel and patients: A role for antimicrobial stewardship programs? (2020). Infection Control & Hospital Epidemiology, 1-6. doi:10.1017/ice.2020.1393
Luther, V.P., Shnekendorf, R., Logan, A...Nori, P., et al. Investing in the Future: A Role for Professional Societies to Prepare the Next Generation of Healthcare Leaders through Curriculum Development and Dissemination, Clinical Infectious Diseases, 2021, ciab244, https://doi.org/10.1093/cid/ciab244
Nori, P., Patel, P., & Stevens, M. (2021). Pandemic stewardship: Reflecting on new roles and contributions of antimicrobial stewardship programs during COVID-19. Infection Control & Hospital Epidemiology, 1-5. doi:10.1017/ice.2021.172
Hoffman, E., Cowman, K., and Nori, P. Respiratory Illness Presenteeism in Academic Medicine...A Conceivable COVID-19 Culture Change for the Better. J. Hosp. Med. 2021 April 21.
Cowman K., Guo Y., Pirofski, L... and Nori P., Post-SARS-CoV-2 monoclonal antibody treatment hospitalizations as a sentinel for emergence of viral variants in New York City, Open Forum Infectious Diseases, 2021;, ofab313, https://doi.org/10.1093/ofid/ofab313
Spicer JO, Armstrong WS, Schwartz BS... Nori P, et. Al. Evaluation of the Infectious Diseases Society of America’s Core Antimicrobial Stewardship Curriculum for Infectious Diseases Fellows, Clinical Infectious Diseases, 2021;, ciab600, https://doi.org/10.1093/cid/ciab600
Assi, M., Abbas, S., Nori, P. et al. Infection Prevention and Antimicrobial Stewardship Program Collaboration During the COVID-19 Pandemic: a Window of Opportunity. Curr Infect Dis Rep 23, 15 (2021). https://doi.org/10.1007/s11908-021-00759-w
Chekuri S., Szymczak, WA, Goldstein DY, Nori P, et al. SARS-CoV-2 coinfection with additional respiratory virus does not predict severe disease: a retrospective cohort study, Journal of Antimicrobial Chemotherapy, Volume 76, Issue Supplement_3, September 2021, Pages iii12–iii19, https://doi.org/10.1093/jac/dkab244
Chang MH, Cowman K, Guo Y, Bao H, Bernstein PS, Gendlina, I, and Nori, P. A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy, American Journal of Obstetrics and Gynecology (2022), doi: https://doi.org/10.1016/j.ajog.2022.01.018.
Bearman, G., Apisarnthanarak, A., Marra, A., Matson, K., Nori, P., Simonsen, K., . . . MacMurray, L. (2022). ASHE December 2021: Reflections on our first year with an eye on the future. Antimicrobial Stewardship & Healthcare Epidemiology, 2(1), E52. doi:10.1017/ash.2021.262
Cowman, K., Rossi, J. Gendlina, I... and Nori, P. Elucidating the role of procalcitonin as a biomarker in hospitalized COVID-19 patients". Diagnostic Microbiology and Infectious Disease. April 2022
Bao, H., Guo, Y., Chang, M., McSweeney, T., Golia, A., Cowman, K., . . . and Nori, P. (2022). Expanding the scope and visibility of ambulatory stewardship programs with novel coronavirus disease 2019 (COVID-19) therapeutics. Antimicrobial Stewardship & Healthcare Epidemiology, 2(1), E73. doi:10.1017/ash.2022.52
Bartash, R., Orner, E., Cowman, K., Szymczak, W., Nori, P., Kornblum, N., & McCort, M. (2022). Does local matter? Evaluating susceptibility variations between hospital-wide and hematology-oncology unit antibiograms. Antimicrobial Stewardship & Healthcare Epidemiology, 2(1), E98. doi:10.1017/ash.2022.36
Nori, P., Stevens, M., & Patel, P. (2022). Rising from the pandemic ashes: Reflections on burnout and resiliency from the infection prevention and antimicrobial stewardship workforce. Antimicrobial Stewardship & Healthcare Epidemiology, 2(1), E101. doi:10.1017/ash.2022.240
Guo, Y., Cowman K., Chang M..., and Nori, P. Assessment of unvaccinated and vaccinated patients with coronavirus disease 2019 (COVID-19) treated with monoclonal antibodies during the delta wave (July 1–August 20, 2021): a retrospective observational monocentric study. BMC Infectious Diseases (2022) 22:645
Cowman, K., Golia, A., Guo, Y....and Nori, P. What is the role of COVID-19 monoclonal antibody programs in promoting post-treatment vaccination. Infectious Diseases in Clinical Practice. Accepted August 2022
Bailey, P., Justo, J., & Nori, P. (2022). Restricted reproductive health and infectious diseases outcomes: A call to action. Antimicrobial Stewardship & Healthcare Epidemiology, 2(1), E137. doi:10.1017/ash.2022.281